Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Stroke. 2016 May 19;47(7):1714–1719. doi: 10.1161/STROKEAHA.115.011392

Table 5.

Association of MRproANP with risk of cardioembolic stroke¥

MRproANP Hazard Ratio* (95% Confidence Interval)
First quartile Reference
Second quartile 1.3 (0.3 – 5.2)
Third quartile 4.2 (1.1– 15.5)
Fourth quartile 16.3 (3.7 – 70.9)
¥

The case group for this analysis includes only those with cardioembolic stroke, and those with other strokes were excluded.

*

adjusted for age, sex, race-ethnicity, education, physical activity, smoking-status, diabetes mellitus, hypertension, cardiac disease, low density lipoprotein (LDL), high density lipoprotein (HDL), estimated glomerular-filtration-rate (eGFR).